Patent ID: 11884734
Assignee: CELLDEX THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 15:
16. The antibody or antigen-binding fragment of claim 14, wherein:
a. the VL comprises:
i. a VL CDR1 comprising the amino acid sequence of SEQ ID NO: 175;
ii. a VL CDR2 comprising the amino acid sequence of SEQ ID NO: 176; and
iii. a VL CDR3 comprising the amino acid sequence of SEQ ID NO: 177; and

b. the VH comprises:
i. a VH CDR1 comprising the amino acid sequence of SEQ ID NO: 172;
ii. a VH CDR2 comprising the amino acid sequence of SEQ ID NO: 173; and
iii. a VH CDR3 comprising the amino acid sequence of SEQ ID NO: 174.